Cardiac magnetic resonance imaging in cardiovascular risk stratification: A narrative review
DOI:
https://doi.org/10.63688/68wsj574Keywords:
Cardiac magnetic resonance, cardiovascular risk, prognosisAbstract
Introduction: Cardiac magnetic resonance (CMR) enables myocardial tissue characterization and quantification of structural and functional parameters relevant to cardiovascular risk assessment.
Objective: To synthesize the available scientific evidence on the utility of cardiac magnetic resonance in cardiovascular risk stratification.
Methodology: A qualitative, descriptive narrative literature review was conducted using publications from PubMed/MEDLINE, Scopus, and SciELO published between January 2021 and July 2026. Studies in English and Spanish evaluating fibrosis, late gadolinium enhancement (LGE), T1/T2 mapping, extracellular volume, perfusion, ventricular function, strain, and prognosis-related parameters were considered. Thirteen studies were included in this research.
Results: CMR identified fibrosis and subclinical tissue abnormalities, while LGE, inducible ischemia, strain, and volumetric parameters were associated with cardiovascular events, arrhythmias, heart failure, and mortality. Their integration improved prognostic discrimination compared with isolated cardiovascular parameters.
Conclusions: CMR provides complementary information for cardiovascular risk stratification and the characterization of structural, tissue, and functional substrates associated with adverse cardiovascular events.
Downloads
References
Abati, E., Alberti, C., Tambè, V., Esseridou, A., Comi, G. P., Corti, S., Meola, G., & Secchi, F. (2024). Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy. Frontiers in Neurology, 15, 1493570. https://doi.org/10.3389/fneur.2024.1493570
Ashkir, Z., Johnson, S., Lewandowski, A. J., Hess, A., Wicks, E., Mahmod, M., Myerson, S., Ebbers, T., Watkins, H., Neubauer, S., Carlhäll, C. J., & Raman, B. (2023). Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis. European Heart Journal–Cardiovascular Imaging, 24(9), 1192–1200. https://doi.org/10.1093/ehjci/jead074
Carerj, M. L., Restelli, D., Poleggi, C., Di Bella, G., Zito, C., Manganaro, R., Cusmà Piccione, M., Trimarchi, G., Farina, A., Micari, A., & Carerj, S. (2025). The role of imaging in cardiovascular prevention: A comprehensive review. Journal of Cardiovascular Echocardiography, 35(1), 8–18. https://doi.org/10.4103/jcecho.jcecho_26_25
Cheng, S., Deng, M., Qi, L., Li, F., Chen, J., Cui, S., Wang, Y., Liu, J., Fan, Y., Xie, L., & Wang, J. (2025). Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: A prospective cardiac magnetic resonance study. Radiology and Oncology, 59(4), 510–521. https://doi.org/10.2478/raon-2025-0043
Cho, E. S., & Roh, S.-Y. (2026). Electromechanical and structural phenotypes from cardiac imaging and epicardial mapping in inherited arrhythmia syndromes. Frontiers in Cardiovascular Medicine, 13, 1900085. https://doi.org/10.3389/fcvm.2026.1900085
Guglielmo, M., Fedele, D., Bergamaschi, L., Armillotta, M., Angeli, F., Ciarlantini, M., Buccella, I., Pizzi, C., Pezel, T., Aquaro, G. D., Baggiano, A., Barison, A., Bogaert, J., Calò, L., Camastra, G., Carigi, S., Carrabba, N., Casavecchia, G., Censi, S., ... Pontone, G. (2026). Cardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction. ESC Heart Failure, 13(3), Article xvag130. https://doi.org/10.1093/eschf/xvag130
Kachhwaha, A., Gaznabi, S., Garg, J., & Tran, D. (2026). Posterior MAD, fibrosis, and bileaflet MVP: A high-risk imaging phenotype for sudden cardiac arrest. JACC: Case Reports, 31(2), 106136. https://doi.org/10.1016/j.jaccas.2025.106136
Kramer, C. M., Kolm, P., DiMarco, J. P., Desai, M. Y., Ho, C. Y., Kwong, R. Y., Dolman, S. F., Desvigne-Nickens, P., Geller, N., Kim, D.-Y., Schulz-Menger, J., Friedrich, M. G., Maron, M. S., Appelbaum, E., Link, M. S., Francis, G. S., Greenberg, B., Jerosch-Herold, M., Piechnik, S., et al. (2026). Predictors of long-term outcomes in hypertrophic cardiomyopathy: The NHLBI HCM Registry. JAMA, 335(22), 1959–1969. https://doi.org/10.1001/jama.2026.5633
Leungratanamart, N., Wanitchung, K., Prechawuttidech, S., Karaketklang, K., & Kaolawanich, Y. (2024). Prognostic value of stress perfusion cardiac magnetic resonance in patients with prediabetes and suspected coronary artery disease. PLOS ONE, 19(10), e0311875. https://doi.org/10.1371/journal.pone.0311875
Masszi, R., Zsigmond, E.-J., Ehrenberger, R., Turan, C., Fehérvári, P., Teutsch, B., Molnár, Z., Drobni, Z., Vágó, H., Hegyi, P., Merkely, B., & Kosztin, A. (2026). Evaluating the predictive value of late gadolinium enhancement assessed by cardiac magnetic resonance on sudden cardiac death in patients selected for implantable cardioverter defibrillator and cardiac resynchronization therapy implantation: A systematic review and meta-analysis. Clinical Research in Cardiology, 115(4), 523–535. https://doi.org/10.1007/s00392-024-02441-2
Matusik, P. S., Mikrut, K., Bryll, A., Popiela, T. J., & Matusik, P. T. (2025). Cardiac magnetic resonance imaging in diagnostics and cardiovascular risk assessment. Diagnostics, 15(2), 178. https://doi.org/10.3390/diagnostics15020178
Nubong, T., Kim, C. W., Khetpal, V., Hulten, E., & Ramirez, V. (2025). Update in cardiovascular prevention: From risk scores to imaging. Rhode Island Medical Journal, 108(2), 9–15. https://pubmed.ncbi.nlm.nih.gov/39878657/
Rowin, E. J., & Schulz, A. (2026). Role of cardiac magnetic resonance imaging in the management of hypertrophic cardiomyopathy. Indian Journal of Thoracic and Cardiovascular Surgery, 42(2), 168–180. https://doi.org/10.1007/s12055-025-02039-x
Wunderly, K., Ajluni, S., O'Hayer, P., & Attili, A. (2026). “Burned-out” hypertrophic cardiomyopathy: Overlap on cardiac MRI with other nonischemic cardiomyopathies. JACC: Case Reports, 31(11), 106940. https://doi.org/10.1016/j.jaccas.2026.106940
Zhang, T.-Y., Lan, T., Wang, L.-L., Zheng, Y.-C., Feng, X.-Y., Wang, F.-Y., Zhang, F., Xu, H.-Y., Liu, X., Yang, Z., & Li, R. (2026). Prognostic value of cardiac magnetic resonance-derived global longitudinal strain in LGE-negative dilated cardiomyopathy. PLOS ONE, 21(3), e0345077. https://doi.org/10.1371/journal.pone.0345077
Zuo, K., Li, K., Xu, L., Wang, Y., Lu, S., Kong, Z., Fu, Z., Zhang, J., Dong, R., Xia, L., Deng, D., & Liu, Z. (2026). Discrimination of sustained VT in structural heart disease using LGE-CMR and computational simulation: Moving beyond LVEF. Frontiers in Cardiovascular Medicine, 13, 1870223. https://doi.org/10.3389/fcvm.2026.1870223
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Richard Fernando Olmedo Vera, Félix Eduardo Alvarado Valdivieso, Michelle Andrea Molina Becerra, Anny Lilibeth Pinargote Santillán, Eunice Rocío Bustamante Romero (Autor/a)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Los artículos publicados en la revista se distribuyen bajo la licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esta licencia permite a terceros descargar, copiar, distribuir, adaptar y reutilizar una obra, incluso con fines comerciales, siempre que se otorgue el crédito adecuado al autor original.
